|
One Thousand Lives A Month
Researcher Estimates 22,000 Lives Could Have Been Saved Had Trasylol Been Pulled Earlier
Source: http://www.cbsnews.com/stories/2008/02/14/60minutes/main3831900.shtml
Possible Trasylol Insiders Should Contact Americas Watchdog ...
Emediawire (press release), WA - Mar 21, 2008
Because of numerous horror story's in the national press, about the drug called Trasylol, Americas Watchdog has initiated a national investigation focused ...
One Thousand Lives A Month
Source: http://www.emediawire.com/releases/2008/3/prweb789524.htm
Trasylol Lawsuit Claims Bayer Failed to Warn of Side Effects
Bayer has been sued over Trasylol, a drug used to prevent bleeding during heart bypass surgery that was withdrawn from the market in May 2008. According to MadisonRecord.com, the lawsuit alleges that Bayer did not warn of the possible serious side effects linked to Trasylol.Trasylol was approved by the US Food & Drug Administration (FDA) 1993 and, before it was withdrawn, had been used in a third of all heart surgery... |
Another Trasylol Study Finds Cheaper Drugs Less Risky
Another study is questioning the safety of Trasylol (aprotinin). Trasylol, a drug made by Bayer for use in cardiac surgery, was withdrawn from the market last year amid safety concerns.Trasylol was approved by the US Food & Drug Administration (FDA) in 1993 and, before it was withdrawn, had been used in a third of all heart surgery patients in the US. However, Trasylol has been the subject of concern for years, and... |
Trasylol Named in Two Lawsuits
Trasylol, Bayer AG's now-withdrawn anti-bleeding medication, is the subject in two Illinois lawsuits. One of the plaintiffs claims Trasylol was the cause of her husband's death, and the other alleges the drug caused him to suffer acute renal failure. Bayer permanently withdrew Trasylol from the market in May 2008, after a study found that it increased patients' risk of death by more than 50 percent.Trasylol was approved by the US Food... |
Trasylol Gone for Good
Trasylol is being removed from the market for good. Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart surgery, in November, after a clinical trial found patients treated with Trasylol were dying at higher rates than others. Now, the results of that trial are in, and the death risk has been confirmed. Yesterday, Bayer notified the Food & Drug Administration (FDA) that it was removing... |
Trasylol Named in 78 Lawsuits, Bayer Says
Bayer AG has been hit with 78 lawsuits over the drug Trasylol. In November, Bayer suspended Trasylol sales after a Canadian study linked it to a higher risk of death.Trayslol was approved in 1993, and was used to prevent bleeding during open heart surgeries. Since its approval, about a third of all heart surgery patients in the US have been treated with Trasylol. Trayslol was the subject of several Food & Drug Administration... |
More Trasylol Studies -- One Previously Withheld by Bayer -- Confirm Death Risks
Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug. Trasylol, manufactured by Bayer AG, was the subject of several Food & Drug Administration (FDA) safety reviews before it was finally pulled from the market last year. One of the newly released studies was completed prior to a September 2006 FDA advisory panel meeting on Trasylol, but was never submitted by... |
FDA Trasylol Failure Could Have Killed Thousands, Researcher Says
Trasylol, a defective drug manufactured by Bayer AG, may have killed 22,000 people before it was pulled from the market last year. Trasylol was withdrawn in November at the request of the Food & Drug Administration (FDA) after an observational study linked the medicine to kidney failure requiring dialysis and increased death of those patients. But a researcher who presented a Trasylol study to the FDA in 2006 told the TV program... |
|
